APG Asset Management N.V. Acquires 304,203 Shares of Stryker Corporation $SYK

APG Asset Management N.V. lifted its holdings in shares of Stryker Corporation (NYSE:SYK) by 47.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 943,648 shares of the medical technology company’s stock after acquiring an additional 304,203 shares during the quarter. Stryker makes up about 0.6% of APG Asset Management N.V.’s portfolio, making the stock its 22nd biggest holding. APG Asset Management N.V. owned 0.25% of Stryker worth $348,838,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Clayton Financial Group LLC bought a new position in Stryker during the third quarter worth $26,000. Elevation Point Wealth Partners LLC bought a new position in shares of Stryker in the second quarter valued at about $28,000. Kilter Group LLC acquired a new stake in shares of Stryker during the 2nd quarter worth about $29,000. Howard Hughes Medical Institute bought a new stake in shares of Stryker during the 2nd quarter worth about $29,000. Finally, ANTIPODES PARTNERS Ltd bought a new stake in shares of Stryker during the 3rd quarter worth about $34,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Stryker Price Performance

SYK stock opened at $387.34 on Friday. The company’s 50-day moving average price is $363.17 and its two-hundred day moving average price is $369.16. The firm has a market cap of $148.23 billion, a P/E ratio of 46.11, a P/E/G ratio of 2.26 and a beta of 0.87. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. Stryker Corporation has a 12 month low of $329.16 and a 12 month high of $404.87.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. The company had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The firm’s quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.01 EPS. On average, analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be paid a $0.88 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 annualized dividend and a dividend yield of 0.9%. Stryker’s dividend payout ratio (DPR) is presently 41.90%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on SYK shares. Weiss Ratings restated a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 22nd. Citigroup restated a “market outperform” rating on shares of Stryker in a research note on Friday, January 30th. BTIG Research upped their price objective on Stryker from $410.00 to $412.00 and gave the company a “buy” rating in a report on Friday, January 30th. Needham & Company LLC lifted their target price on Stryker from $448.00 to $454.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Finally, Robert W. Baird set a $437.00 target price on shares of Stryker in a research report on Friday, January 30th. Thirteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $426.47.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director directly owned 2,457,331 shares in the company, valued at $891,814,566.52. This represents a 9.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 5.90% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.